Valence Labs Research
Sermorelin
Growth Hormone Research Peptide
- Compound
- Sermorelin
- Category
- Research Peptide
- Available Variant
- 10mg
- Research Status
- Research Use Only
Overview
Sermorelin is an analogue of growth hormone-releasing hormone corresponding to GHRH(1-29). It is studied in growth hormone-releasing hormone receptor research and pituitary signaling.
Research interest includes GH-axis biology and structure–activity relationships of the GHRH(1-29) sequence.
Research Areas
GHRH Receptor Research
Sermorelin is studied as a GHRH(1-29) analogue in growth hormone-releasing hormone receptor research.
Pituitary Signaling
Research examines how this analogue relates to pituitary signaling within the GH axis.
Structure–Activity Research
Published structure–activity studies of hGHRH(1-29) have been used to examine how peptide sequence relates to GH-axis signaling.
How It Is Being Studied
Sermorelin and related GHRH(1-29) analogues have been examined in receptor, pituitary-signaling, and structure–activity research.
This page summarizes published research contexts. It does not present the Valence Labs catalog product as a therapeutic or provide treatment recommendations.
Specifications
Catalog details for this product.
- Product Name
- Sermorelin
- Category
- Research Peptide
- Variant
- 10mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Documentation will appear here as records are published.
References
Available Product
Sermorelin
10mg